Honglei Wu
- Cancer Research top 10%
- Cancer-related molecular mechanisms research 3
- Cancer, Hypoxia, and Metabolism 2
-
- RNA modifications and cancer 3
- Circular RNAs in diseases 2
- Genomics, phytochemicals, and oxidative stress 1
-
- Photodynamic Therapy Research Studies 2
-
- Nanoplatforms for cancer theranostics 2
-
- Cholesterol and Lipid Metabolism 1
- Journals
- Molecular Therapy (1 paper)Life Sciences (1 paper)International Journal of Pharmaceutics (1 paper)
- Partner nations
- ChinaUnited States
In The Last Decade
Honglei Wu
7 papers receiving 392 citations
Peers
Comparison fields: 5 of 56
- Cancer Research 212
- Molecular Biology 245
- Pulmonary and Respiratory Medicine 88
- Biomedical Engineering 94
- Immunology 45
Countries citing papers authored by Honglei Wu
This map shows the geographic impact of Honglei Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Honglei Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Honglei Wu more than expected).
Fields of papers citing papers by Honglei Wu
This network shows the impact of papers produced by Honglei Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Honglei Wu. The network helps show where Honglei Wu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Honglei Wu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 0 | |
| 3 | 2023 | 0 | |
| 4 | 2022 | 25 | |
| 5 | 2021 | 103 | |
| 6 | 2021 | 25 | |
| 7 | 2020 | 184 | |
| 8 | 2019 | 32 | |
| 9 | 2011 | 23 |
About Honglei Wu
Honglei Wu is a scholar working on Cancer Research, Pulmonary and Respiratory Medicine and Surgery, having authored 9 papers that have together received 393 indexed citations. Recurring topics across this work include RNA modifications and cancer (3 papers), Cancer-related molecular mechanisms research (3 papers), Cancer, Hypoxia, and Metabolism (2 papers), Circular RNAs in diseases (2 papers), Nanoplatforms for cancer theranostics (2 papers), Photodynamic Therapy Research Studies (2 papers), Cholesterol and Lipid Metabolism (1 paper) and Genomics, phytochemicals, and oxidative stress (1 paper). The work is most often cited by research in Cancer Research (212 citations), Molecular Biology (245 citations) and Pulmonary and Respiratory Medicine (88 citations). Honglei Wu has collaborated with scholars based in China and United States. Frequent co-authors include Bin Liu, Zhaosheng Chen, Guangchun Li, Zhen Zhang, Yueping Zhan, Zeting Yuan, Peihao Yin, Feng Gao, Zhen Zhang and Jun Zhang. Their work appears in journals such as Molecular Therapy, Life Sciences, International Journal of Pharmaceutics, Cancer Cell International and Cell Death and Disease.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.